Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Thalamus pathology in multiple sclerosis: from biology to clinical application.
Anxiety, depression and impaired health-related quality of life are therapeutic challenges in patients with multiple sclerosis.
FDA reversal sends mixed message to multiple sclerosis community.
The magnetic resonance imaging appearance of monophasic acute disseminated encephalomyelitis: an update post application of the 2007 consensus criteria.
Vitamin D During Pregnancy and Multiple Sclerosis: An Evolving Association.
Clinical Characteristics and Urodynamic Analysis of Urinary Dysfunction in Multiple Sclerosis.
3D models of human ERα and ERβ complexed with 5-androsten-3β,17β-diol.
Acute-onset multifocal motor neuropathy (AMMN):how we meet the diagnosis.
Molecular alterations of the blood-brain barrier under inflammatory conditions: The role of endothelial to mesenchymal transition.
IV immunoglobulin confounds JC virus antibody serostatus determination.
Successful treatment of neuromyelitis optica spectrum disorder by early initiation of plasma exchange.
Anesthetic technique in a patient with multiple sclerosis scheduled for laparoscopic nephrectomy for a renal tumor: a case report.
Visual search as a tool for a quick and reliable assessment of cognitive functions in patients with multiple sclerosis.
[Reflections on the outcome measures in the clinical trials of multiple sclerosis].
Towards Clinical Application of Mesenchymal Stem Cells for Treatment of Neurological Diseases of the Central Nervous System.
Role of Hemichannels in CNS Inflammation and the Inflammasome Pathway.
Neurodegeneration Triggers Peripheral Immune Cell Recruitment into the Forebrain.
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.
Fingolimod for relapsing-remitting multiple sclerosis.
Potential For Cell-mediated Immune Responses In Mouse Models Of Pelizaeus-Merzbacher Disease.
Inflammatory Cytokines and Physical Activity in Multiple Sclerosis.
The contribution of assessing cognitive impairment in radiologically-isolated syndrome (RIS): A single case report follow-up study.
Suppression of miR-155 Expression in IFN-γ-Treated Astrocytes and Microglia by DJ-1: A Possible Mechanism for Maintaining SOCS1 Expression.
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med
SPECIFIC TARGETING OF THE IL-23 RECEPTOR USING A NOVEL SMALL PEPTIDE NON-COMPETITIVE ANTAGONIST, DECREASES THE INFLAMMATORY RESPONSE.
Pages
« first
‹ previous
…
579
580
581
582
583
584
585
586
587
…
next ›
last »